You have probably heard about CBD, either from the media or in person, especially in regard to its medical potential. Cannabidiol (“CBD”) came into the limelight when the 2018 farm bill federally legalized the cultivation and sale of industrial hemp and its derivatives, including CBD. Although hemp is in the cannabis family, CBD extracted from legal industrial hemp will not intoxicate you. However, CBD still shares plenty of medical properties with THC, the main psychoactive agent in marijuana, and several studies have found that cannabidiol can aid in post-cancer recovery.
So how exactly does taking CBD aid in post-cancer recovery? It all boils down to potent anti-inflammation and antioxidant properties. CBD is most commonly used to address issues such as chronic pain, anxiety, depression, nausea and insomnia. Some studies have also found that cannabinoids such as CBD can inhibit tumor growth and reduce tumor invasion. However, more research is needed before we can conclusively state that CBD is an effective anti-cancer treatment. However, at the moment, cannabinoid does look to be able to support post-cancer recovery.
Coincidentally, most of the adverse symptoms caused by cancer treatments such as radiation and chemotherapy can be treated by CBD treatment. These symptoms include nausea, insomnia, loss of appetite and neuropathic pain. Recovering from cancer can be brutal as the treatments aren’t easy on the body. Lack of appetite, for instance, can significantly reduce your food intake, reducing your energy levels and actually hindering your recovery. Since CBD is known to stimulate appetite, individuals undergoing cancer treatment can use it to maintain sufficient nutrient intake and give their bodies the energy it needs to recover.
This is the same for insomnia, which will not only make you feel tired and fatigued but can also put your health at even more risk. CBD is also thought to be a pain reliever, and it can be effective against the sometimes severe pain cancer patients feel. All cannabinoids, including CBD and THC, create their therapeutic effects by interacting with the endocannabinoid system (“ECS”), a part of the nervous system that’s in charge of regulating processes such as hunger, sleep and pain. Essentially, the ECS is a system that works to maintain homeostasis, or the body’s internal balance.
If you would like to use CBD to aid in cancer recovery, make sure to speak to your doctor first. Additionally, you should not ditch your cancer medication for CBD; while some studies have found that it has anti-cancer effects, it isn’t an effective treatment against cancer.
Such cannabis-based treatments may stand a higher chance of being beneficial when taken using an IoT-enabled dose-measuring device such as those produced by RYAH Group Inc. (CSE: RYAH) and other such companies.
NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. (CSE: RYAH) are available in the company’s newsroom at https://cnw.fm/RYAH
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.
